|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.25 EUR | -1.17% |
|
+6.39% | -5.29% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.12% | -1.90% | -3.01% | +24.48% | +8.25% | +53.06% | +155.94% | +377.76% | +1,298.60% | 1,079B | |
| -3.58% | -1.47% | +0.59% | +11.14% | +23.44% | +52.73% | +52.49% | +48.35% | +103.72% | 640B | |
| -2.79% | -0.47% | +1.62% | +21.01% | +11.92% | +35.08% | +70.96% | +119.88% | +282.01% | 465B | |
| -2.14% | +1.00% | +6.07% | +10.87% | +7.56% | +35.98% | +30.45% | +0.76% | +43.85% | 353B | |
| -2.17% | -0.61% | +0.24% | +9.47% | +15.77% | +33.53% | +39.32% | +51.26% | +59.30% | 301B | |
| -2.82% | +0.69% | -9.39% | -8.40% | -7.35% | +11.11% | +14.21% | +54.52% | +152.19% | 271B | |
| -2.15% | +3.22% | +5.09% | +21.43% | +1.64% | +1.72% | -39.46% | +14.00% | +73.59% | 228B | |
| -1.89% | +2.12% | +4.77% | +9.57% | +15.91% | +25.89% | +62.02% | +57.07% | +117.83% | 209B | |
| -2.72% | -1.31% | +2.22% | -1.30% | +5.22% | +12.53% | +69.62% | +89.11% | +60.51% | 165B | |
| -2.05% | -1.69% | +2.11% | -7.91% | -1.26% | +3.27% | -31.82% | -42.57% | -34.10% | 143B | |
| +1.24% | +5.14% | +12.24% | +6.73% | +19.89% | +40.65% | +3.99% | -4.71% | -15.12% | 129B | |
| -2.17% | -0.34% | -5.08% | +10.32% | +4.00% | +0.50% | +33.82% | +133.90% | +380.13% | 123B | |
| -9.03% | -4.82% | -3.20% | -8.95% | -12.14% | -15.01% | -25.14% | -16.34% | -4.71% | 109B | |
| -3.08% | +2.36% | -1.54% | +1.14% | +6.91% | +33.37% | +40.87% | +10.06% | -8.24% | 106B | |
| +0.03% | -1.96% | -6.15% | -12.88% | -14.22% | -4.52% | +67.12% | +75.90% | +449.56% | 70.98B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -2.21% | +3.87% | +10.92% | +8.50% | +18.26% | +33.10% | +31.72% | +55.30% | +19.12% | 56.98B | |
| +1.52% | +4.74% | -0.04% | +27.17% | +30.75% | +71.57% | -8.94% | -3.78% | -49.78% | 53.32B | |
| +1.13% | -2.71% | +1.81% | -2.00% | -9.54% | -15.53% | +9.87% | -2.21% | +232.58% | 52.55B | |
| Average | -2.04% | +2.71% | +1.07% | +6.69% | +6.95% | +22.72% | +32.06% | +56.57% | +175.61% | 243.03B | |
| Weighted average by Cap. | -2.85% | +3.39% | +0.24% | +12.17% | +9.41% | +33.64% | +62.59% | +125.56% | +396.50% |
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
